Defining precancer: a grand challenge for the cancer community.

Saved in:
Bibliographic Details
Title: Defining precancer: a grand challenge for the cancer community.
Authors: Faupel-Badger J; Division of Cancer Prevention, National Cancer Institute, NIH, Rockville, MD, USA., Kohaar I; Division of Cancer Prevention, National Cancer Institute, NIH, Rockville, MD, USA., Bahl M; Division of Breast Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Campbell JD; Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Ding L; Department of Medicine and Genetics, McDonnell Genome Institute, and Siteman Cancer Center, Washington University in St Louis, Saint Louis, MO, USA., De Marzo AM; Department of Pathology, Urology and Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Maitra A; Department of Translational Molecular Pathology, Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Merrick DT; Division of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Hawk ET; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lippman SM; Department of Medicine, University of California, La Jolla, San Diego, CA, USA., Lu KH; Department of Gynecological Oncology, Moffitt Cancer Center, Tampa, FL, USA., Lawler M; Patrick G Johnson Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Tlsty TD; Department of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Rebbeck TR; Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA., Srivastava S; Division of Cancer Prevention, National Cancer Institute, NIH, Rockville, MD, USA. srivasts@mail.nih.gov.
Corporate Authors: Precancer Think Tank Team
Source: Nature reviews. Cancer [Nat Rev Cancer] 2024 Nov; Vol. 24 (11), pp. 792-809. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-1768
DOI:10.1038/s41568-024-00744-0